Free Access
Med Sci (Paris)
Volume 19, Number 12, Décembre 2003
Page(s) 1251 - 1258
Section M/S revues
Published online 15 December 2003
  1. Gething MJ. Guidebook to molecular chaperones and protein-folding catalysts. Oxford : Sambrook and Tooze Publication. Oxford University Press, 1997 : 554 p. [Google Scholar]
  2. Ferrari DM, Söling HD. The protein disulphide-isomerase family: unravelling a string of folds. Biochem J 1999; 339 : 1–10. [Google Scholar]
  3. Schmid FX. Prolyl isomerase : enzymatic catalysis of slow protein-folding reactions. Annu Rev Biophys Biomol Struct 1993; 22 : 123–43. [Google Scholar]
  4. Fischer G, Bang H, Mech C. Detection of enzyme catalysis for cis-trans isomerization of peptide bonds using proline containing peptides as substrates. Biochem Biomed Acta 1984; 43 : 1101–12. [Google Scholar]
  5. Dolinski K, Muir S, Cardenas M, Heitman J. All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1997; 94 : 13093–8. [Google Scholar]
  6. Hanes SD, Shank PR, Bostian KA. Sequence and mutational analysis of ESS1, a gene essential for growth in Saccharomyces cerevisiae. Yeast 1989; 5 : 55–72. [Google Scholar]
  7. Rahfeld JU, Rucknagel KP, Schelbert B, et al. Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin. FEBS Lett 1994; 352 : 180–4. [Google Scholar]
  8. Hennig L, Christner C, Kipping M, et al. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 1998; 37 : 5953–60. [Google Scholar]
  9. Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996; 380 : 544–7. [Google Scholar]
  10. Lu PJ, Zhou XZ, Shen M, Lu KP. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999; 283 : 1325–8. [Google Scholar]
  11. Verdecia MA, Bowman ME, Lu KP, Hunter T, Noel JP. Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat Struct Biol 2000; 7 : 639–43. [Google Scholar]
  12. Yaffe MB, Schutkowski M, Shen M, et al. Sequence-specific and phosphorylation-dependent proline isomerization : a potential mitotic regulatory mechanism. Science 1997; 278 : 1957–60. [Google Scholar]
  13. Shen M, Stukenberg PT, Kirschner MW, Lu KP. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev 1998; 12 : 706–20. [Google Scholar]
  14. Crenshaw DG, Yang J, Means AR, Kornbluth S. The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. Embo J 1998; 17 : 1315–27. [Google Scholar]
  15. Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999; 399 : 784–8. [Google Scholar]
  16. Pathan N, Aime-Sempe C, Kitada S, Haldar S, Reed JC. Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1. Neoplasia 2001; 3 : 70–9. [Google Scholar]
  17. Liu W, Youn HD, Zhou XZ, Lu KP, Liu JO. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1. FEBS Lett 2001; 496 : 105–8. [Google Scholar]
  18. Wulf GM, Ryo A, Wulf GG, et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 2001; 20 : 3459–72. [Google Scholar]
  19. Ryo A, Nakamura M, Wulf G, Liou YC, Lu KP. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 2001; 3 : 793–801. [Google Scholar]
  20. Liou YC, Ryo A, Huang HK, et al. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci USA 2002; 99 : 1335–40. [Google Scholar]
  21. Kamimoto T, Zama T, Aoki R, Muro Y, Hagiwara M. Identification of a novel kinesin-related protein, KRMP1, as a target for mitotic peptidyl-prolyl isomerase Pin1. J Biol Chem 2001; 276 : 37520–8. [Google Scholar]
  22. He J, Lau AG, Yaffe MB, Hall RA. Phosphorylation and cell cycle-dependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase. J Biol Chem 2001; 276 : 41559–65. [Google Scholar]
  23. Albert A, Lavoie S, Vincent M. A hyperphosphorylated form of RNA polymerase II is the major interphase antigen of the phosphoprotein antibody MPM-2 and interacts with the peptidyl-prolyl isomerase Pin1. J Cell Sci 1999; 112 : 2493–500. [Google Scholar]
  24. Lavoie SB, Albert AL, Handa H, Vincent M, Bensaude O. The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9. J Mol Biol 2001; 312 : 675–85. [Google Scholar]
  25. Stukenberg PT, Kirschner MW. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol Cell 2001; 7 : 1071–83. [Google Scholar]
  26. Patra D, Wang SX, Kumagai A, Dunphy WG. The xenopus Suc1/Cks protein promotes the phosphorylation of G(2)/M regulators. J Biol Chem 1999; 274 : 36839–42. [Google Scholar]
  27. Lu PJ, Zhou XZ, Liou YC, Noel JP, Lu KP. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J Biol Chem 2002; 277 : 2381–4. [Google Scholar]
  28. Zhou XZ, Kops O, Werner A, et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 2000; 6 : 873–83. [Google Scholar]
  29. Fujimori F, Takahashi K, Uchida C, Uchida T. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem Biophys Res Commun 1999; 265 : 658–63. [Google Scholar]
  30. Fujimori F, Gunji W, Kikuchi J, et al. Crosstalk of prolyl isomerases, Pin1/Ess1, and cyclophilin A. Biochem Biophys Res Commun 2001; 289 : 181–90. [Google Scholar]
  31. Iqbal K, Alonso AC, Gong CX, et al. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J Neural Tansm 1998; 53 (suppl) : 169–80. [Google Scholar]
  32. Spillantini MG, Goedert M. Tau protein pathology in neurogenerative diseases. Trends Neurosci 1998; 21 : 428–33. [Google Scholar]
  33. Bramblett GT, Goedert M, Jakes R, et al. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993; 10 : 1089–99. [Google Scholar]
  34. Mandelkow E, Song YH, Schweers O, Marx A, Mandelkow EM. On the structure of microtubules, tau, and paired helical filaments. Neurobiol Aging 1995; 16 : 347–54. [Google Scholar]
  35. Bensaude O, Bellier S, Dubois MF. Le domaine carboxy-terminal (CTD) de l'ARN polymérase II : un pivot du métabolisme des ARN messagers en général et du VIH en particulier. Med Sci 1998; 14 : 167–74. [Google Scholar]
  36. Morris DP, Phatnani HP, Greenleaf AL. Phospho-carboxyl-terminal domain binding and the role of a prolyl isomerase in pre-mRNA 3'-end formation. J Biol Chem 1999; 274 : 31583–7. [Google Scholar]
  37. Winkler KE, Swenson KI, Kornbluth S, Means AR. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 2000; 287 : 1644–7. [Google Scholar]
  38. Zacchi P, Gostissa M, Uchida T, et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002; 419 : 853–7. [Google Scholar]
  39. Zheng H, You H, Zhou XZ, et al. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002; 419 : 849–53. [Google Scholar]
  40. Lu KP, Liou YC, Vincent I. Proline-directed phosphorylation and isomerization in mitotic regulation and in Alzheimer’s Disease. BioEssays 2003; 25 : 174–81. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.